Benlong (Benidipine Hydrochloride)

• Composition :
  Each tablet contains Benidipine Hydrochloride of 4mg/8mg.
• Indications :
  Indicated for the treatment of hypertension and long term prophylactic management of angina pectoris.
• Pharmacodynamics :
  Benidipine is a dihydropyridine-derived calcium channel blocker.Benidipine blocks ‘L’ and ‘N’ type Ca2+ channels cause vasodilationand blocks ‘T’ type Ca2+ channels in adrenal glands and in kidney thus, reduces the production of aldosterone.
• Dosage and administration :
  In adults for Hypertension 4 mg once dailyif necessary increase to 8 mg once daily.In angina pectoris 4 mg twice daily.
• Contraindications :
  Contraindicated in patients with hypersensitivity to any component in the product.
• Precautions and warnings :
  Abrupt withdrawal of the drug should not be done. Periodic assessment of renal function is necessary.
• Use in pregnancy, lactation & pediatrics :
  Not recommended in pregnancy and lactation. Safety and effectiveness of benidipinein pediatric populationhave not been established.
• Drug interactions :
  Monitoring of the serum concentration forDigoxin is recommended and caution should be excised during concomitant use with diuretics and β blocker.
• Adverse reactions :
  The most common adverse events are headache, dizziness,
• Therapy Area :
  Anti-Hypertensives